Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases.

Beckers, A; Petrossians, P; Abs, R; Flandroy, P; Stadnik, T; de Longueville, M; Lancranjan, I; Stevenaert, A

Beckers, A; Petrossians, P; Abs, R; Flandroy, P; Stadnik, T; de Longueville, M; Lancranjan, I; Stevenaert, A.

Affiliation

Beckers A; Department of Endocrinology, University of Liège, Belgium.

J Clin Endocrinol Metab ; 75(1): 275-80, 1992 Jul.

Article in En | MEDLINE | ID: mdl-1619019

Subject(s)

Bromocriptine/therapeutic use; Pituitary Neoplasms/drug therapy; Prolactinoma/drug therapy; Adult; Aged; Bromocriptine/administration & dosage; Bromocriptine/adverse effects; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Nausea/chemically induced; Pituitary Gland/physiology; Prolactin/blood; Prolactin/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Prolactinoma / Bromocriptine Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 1992 Document type: Article Affiliation country: Belgium

Search on Google

Add to My VHL

XML

PubMed Links